Tuesday, October 26, 2021
Home Climate411 “Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

-

The use of Remdesivir for COVID-19 was authorized by the FDA based on a single RCT, conducted by NIAID with the participation of Gilead Sciences, the exclusive manufacturer of Remdesivir. A final report from this study was published on October 8, five months after the drug’s authorization.

- Advertisment -

Related Articles

Texas to United Nations: Pound Sand

The world is reeling from spiraling fuel costs caused by premature over-reliance on renewable energy. High fuel costs punish middle class families & stoke...

Chinese President: COP26 a “wake-up call … to mankind”

The Australian newspaper has praised President Xi Jinping, though the reporter admits China's policy of churning out coal plants and mining coal as quickly...

Climate Alarmist Deception Distorting Long Established U.S. Heat Wave Data

Biden and the Democrat's Administration scientifically unsupported “extreme heat" politics is promoting climate alarmist advocates to manufacture politically contrived  deceptive propaganda schemes using graphically...